| pubmed-article:18662967 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0079744 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0282491 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C1442989 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C1883712 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:18662967 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
| pubmed-article:18662967 | pubmed:issue | 28 | lld:pubmed |
| pubmed-article:18662967 | pubmed:dateCreated | 2008-9-30 | lld:pubmed |
| pubmed-article:18662967 | pubmed:abstractText | Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] DLBCL), which initially were characterized by gene expression profiling and subsequently were confirmed by immunostaining. However, with the addition of rituximab to standard chemotherapy, the prognostic significance of this subclassification of DLBCL is unclear. | lld:pubmed |
| pubmed-article:18662967 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18662967 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662967 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18662967 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:18662967 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:WeisenburgerD... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:VoseJulie MJM | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:BiermanPhilip... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:ChanWing CWC | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:ArmitageJames... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:GreinerTimoth... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:HansChristine... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:FuKaiK | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:ChoiWilliam... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:SmithLynette... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:BociekR... | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:PerryKyle DKD | lld:pubmed |
| pubmed-article:18662967 | pubmed:author | pubmed-author:ShiXinlanX | lld:pubmed |
| pubmed-article:18662967 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18662967 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18662967 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:18662967 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18662967 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18662967 | pubmed:pagination | 4587-94 | lld:pubmed |
| pubmed-article:18662967 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:meshHeading | pubmed-meshheading:18662967... | lld:pubmed |
| pubmed-article:18662967 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18662967 | pubmed:articleTitle | Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. | lld:pubmed |
| pubmed-article:18662967 | pubmed:affiliation | Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA. | lld:pubmed |
| pubmed-article:18662967 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18662967 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662967 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662967 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662967 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662967 | lld:pubmed |
